[Ingredients]: The main component of this product is acetylglutamine. The auxiliary material is mannitol.
[Chemical Name]: N2-acetyl-L-glutamine
[Indication]: Used for traumatic coma, neurosurgery caused by coma, liver coma and hemiplegia, high paraplegia, polio sequelae, nerve headache, and lumbpain, etc.
[Specification]: (1) 0.3g | (2) 0.6g
[Usage and Dosage]:
[Untoward Effect]: Potential reactions include:
[Points for Attention]:
Pharmacological Toxicology: Acetylglutamine decomposes into glutamate and γ-aminobutyric acid (GABA) after passing through the blood-cerebrospinal fluid barrier. It improves nerve cell metabolism, maintains nerve stress ability, reduces blood ammonia, and improves brain function.
Pharmacokinetics: Widely distributed in the body (highest in brain, liver, and kidney). It passes through the blood-cerebrospinal fluid barrier. Ammonia is secreted and excreted through renal tubules, while acetylglutamate is absorbed for metabolism.
| Store Hidden | Shading, closed preservation. |
| Packaging | Vial box, 6 vials / box |
| Expiry Date | 24 months |
| Implementation Standard | YBH12832005-2014Z |
| Approval No. | H20050987 / H20050988 |